Study guide
7.2 Bone Remodelling and the RANK/RANKL/OPG Axis
Overseas Registration Examination ORE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy
1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits
2 Chapter 2: Anatomy of the Head and Neck
2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection
3 Chapter 3: Dental Anatomy, Morphology and Occlusion
3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships
4 Chapter 4: Genetics, Embryology and Odontogenesis
4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies
5 Chapter 5: Oral Biology and Salivary Physiology
5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics
6 Chapter 6: Physiology of the Major Body Systems
6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System
7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing
7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk
8 Chapter 8: Oral Microbiology and Biofilm Ecology
8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control
9 Chapter 9: Immunology Relevant to Oral Disease
9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations
10 Chapter 10: General Pathology and Neoplasia
10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma
11 Chapter 11: Statistics and Research Methods
11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance
12 Chapter 12: Human Disease: Cardiovascular and Respiratory
12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies
13 Chapter 13: Human Disease: Endocrine, Haematological and Renal
13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis
14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological
14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis
15 Chapter 15: Oral Aspects of Human Disease
15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis
16 Chapter 16: Infection Prevention and Control
16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses
17 Chapter 17: Dental Materials
17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers
18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care
18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health
19 Chapter 19: Patient Assessment and Diagnosis
19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis
20 Chapter 20: Treatment Planning and Risk-Based Care
20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning
21 Chapter 21: Cariology and Caries Risk Assessment
21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment
22 Chapter 22: Operative Dentistry and Minimal Intervention
22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry
23 Chapter 23: Endodontics
23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture
24 Chapter 24: Periodontology
24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care
25 Chapter 25: Fixed Prosthodontics
25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements
26 Chapter 26: Removable Prosthodontics
26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration
27 Chapter 27: Paediatric Dentistry
27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits
28 Chapter 28: Dental Traumatology
28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications
29 Chapter 29: Orthodontics
29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention
30 Chapter 30: Oral Surgery
30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread
31 Chapter 31: Oral Medicine
31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
32 Chapter 32: Oral Pathology
32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms
33 Chapter 33: Therapeutics and Prescribing
33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics
34 Chapter 34: Medical Emergencies in Dental Practice
34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation
35 Chapter 35: Dental Radiology and Radiation Protection
35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017
36 Chapter 36: Special Care Dentistry and Conscious Sedation
36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral
37 Chapter 37: Dental Public Health
37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning
38 Chapter 38: Communication and Interpersonal Skills
38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team
39 Chapter 39: Consent and Capacity
39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure
40 Chapter 40: Clinical Professionalism and the GDC
40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle
41 Chapter 41: Health and Safety Law in Dental Practice
41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps
42 Chapter 42: Self-Management and Professional Development
42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management
7.2 Bone Remodelling and the RANK/RANKL/OPG Axis
Key Takeaways Explain This Topic AI
Osteoblasts differentiate from mesenchymal stem cells under Runx2 and Osterix control and deposit osteoid at roughly 1 micrometre per day.
Osteocytes make up more than 90% of bone cells and communicate through canaliculi and connexin 43 gap junctions.
Osteocyte-derived sclerostin inhibits Wnt/beta-catenin signalling through LRP5/6 and suppresses bone formation.
Osteoclasts arise from the monocyte-macrophage lineage and require M-CSF and RANKL for differentiation.
Osteoprotegerin is a soluble decoy receptor that binds RANKL and prevents it reaching RANK, so net bone loss is governed by the RANKL to osteoprotegerin ratio.
Last updated: September 2026
2. Cellular Kinetics of Bone Remodelling: The Basic Multicellular Unit (BMU)
Bone is continuously renewed through targeted coupling of osteoclastic bone resorption and osteoblastic bone formation executed by the Basic Multicellular Unit (BMU) . Alveolar bone exhibits one of the highest turnover rates in the human skeleton due to constant masticatory loading and occlusal demands. ┌───────────────────────────────────────────────────────────┐
- ▼ │
- 1. ACTIVATION ──▶ 2. RESORPTION ──▶ 3. REVERSAL ──▶ 4. FORMATION ──▶ 5. QUIESCENCE
- Osteoclast Osteoclast seals Macrophages Osteoblasts Osteocytes
- precursors Howship's lacuna clean debris; deposit osteoid; entomb in bone;
- recruited Pumps H+ & Cement line Mineralize via Inhibit Wnt via
- (RANKL binding) Cathepsin K deposited ALP vesicles Sclerostin
- Bone Cell Lineages and Biological Mechanics
Osteoblasts:
Derived from local mesenchymal stem cells (MSCs) under the master transcriptional control of Runx2 (Cbfa1) and Osterix (Osx) .
Cuboidal, mononucleated cells that line bone-forming surfaces. Highly active osteoblasts possess abundant rough endoplasmic reticulum and prominent Golgi apparatuses to synthesize and secrete the organic bone matrix ( osteoid ).
Osteoid Composition: 90% Type I collagen and 10% non-collagenous proteins ( osteocalcin , osteopontin , bone sialoprotein ).
Mineralization Function: Osteoblasts express high levels of membrane-bound Tissue Non-Specific Alkaline Phosphatase (TNAP / ALP) on their external membranes. ALP hydrolyses inorganic pyrophosphate (PPᵢ, a potent natural inhibitor of calcification) into free inorganic phosphate (Pᵢ). This elevates local phosphate concentrations, driving the nucleation and precipitation of calcium and phosphate into hydroxyapatite crystals [Ca₁₀(PO₄)₆(OH)₂] within extracellular matrix vesicles.
Osteocytes:
Mature terminal cells derived from osteoblasts that become engulfed within the newly mineralized matrix, residing inside microscopic cavities termed lacunae .
Represent >90–95% of all bone cells in the adult skeleton, with an exceptional lifespan spanning decades.
Maintain an extensive three-dimensional syncytial network via dendritic cytoplasmic processes traversing radiating canaliculi . Processes communicate directly with adjacent osteocytes and surface lining cells through connexin 43 (Cx43) gap junctions .
Mechanotransduction: Osteocytes are the master mechanosensory cells of bone. Interstitial fluid flow through the canalicular network under mechanical shear stress generates fluid shear stress across osteocyte membranes. This triggers intracellular calcium influx, nitric oxide (NO) generation, and prostaglandin E₂ (PGE₂) release, instructing osteoblasts to deposit new bone along stress lines (Wolff's Law).
Sclerostin Regulation: When bone is unloaded or disused (e.g., following tooth extraction), osteocytes secrete sclerostin (encoded by the SOST gene). Sclerostin binds to LRP5/6 receptors on osteoblasts, inhibiting canonical Wnt/β-catenin signalling and halting bone formation. Mechanical loading downregulates sclerostin, releasing Wnt inhibition and stimulating bone accretion.
Osteoclasts:
Derived from haematopoietic stem cells of the monocyte/macrophage lineage under the dual stimulation of Macrophage Colony-Stimulating Factor (M-CSF) and RANKL .
Terminally differentiated, multinucleated giant cells (containing 4 to 20 nuclei) expressing high levels of Tartrate-Resistant Acid Phosphatase (TRAP) .
Resorption Cycle:
Attachment and Polarization: Osteoclasts attach to mineralized bone surfaces via αvβ3 integrins binding to Arg-Gly-Asp (RGD) motifs of osteopontin and bone sialoprotein. This forms a specialized, actin-rich circumferential sealing zone (clear zone) , isolating the sub-osteoclastic microenvironment from the extracellular fluid.
Ruffled Border Formation: Massive fusion of secretory lysosomes with the enclosed apical membrane creates the ruffled border —a highly folded membrane surface.
Acidification (Inorganic Dissolution): Cytoplasmic carbonic anhydrase II (CA II) generates protons (H⁺). The osteoclast actively pumps H⁺ across the ruffled border into the sealed resorption pit ( Howship's lacuna ) using electrogenic vacuolar-type H⁺-ATPase (V-ATPase) pumps, driving the lacunar pH down to ~4.5 . This intense acidity dissolves the inorganic hydroxyapatite crystals, liberating Ca²⁺ and PO₄³⁻.
Enzymatic Degradation (Organic Cleavage): The osteoclast exocytoses lysosomal Cathepsin K and Matrix Metalloproteinases (MMP-9) into the acidic lacuna. Cathepsin K cleaves the telopeptide and triple-helix domains of demineralized Type I collagen, leaving behind a scooped-out Howship's lacuna.
The Remodelling Sequence (BMU Lifecycle)
Activation Phase (Days): Physical microdamage, mechanical disuse, or inflammatory cytokines (IL-1, TNF-α) trigger osteocyte apoptosis or signal lining cells to withdraw, exposing mineralized bone. Osteoclast precursors are recruited from blood vessels.
Resorption Phase (2 to 4 Weeks): Multinucleated osteoclasts excavate Howship's lacunae to a programmed depth.
Reversal Phase (1 to 2 Weeks): Osteoclasts detach and undergo apoptosis. Mononuclear macrophage-like reversal cells debride remaining organic matrix debris and deposit a proteoglycan-rich, non-collagenous adhesive layer known as the cement line (reversal line) , which anchors newly formed bone to the old bone bed.
Formation Phase (3 to 4 Months): Differentiated osteoblasts migrate into the lacuna, laying down unmineralized osteoid in organized lamellae at ~1 μm/day.
Mineralization Phase: Primary mineralization achieves ~70% mineral content within days; secondary mineralization slowly completes over months.
Quiescence: Osteoblasts either flatten to become inactive bone lining cells, undergo apoptosis, or become entombed as osteocytes.
3. The Molecular RANK/RANKL/OPG Axis in Health and Disease
The coupling of bone resorption and formation is orchestrated at the molecular level by three members of the tumour necrosis factor (TNF) and TNF-receptor superfamilies: ┌────────────────────────────┐
- │ Osteoblast / Stroma │
- └──────────────┬─────────────┘
- │ Secretes
- ┌──────────────────┴──────────────────┐
- ▼ ▼
- [ RANKL ] [ OPG ] (Soluble Decoy)
- │ │
- │ Interception / Neutralization │
- │ ◀───────────────────────────────────┘
- │ (Prevents RANK activation)
- ▼
- [ RANK ] (Transmembrane Receptor)
- │
- [ Osteoclast Precursor ]
- │
- ▼ (Recruits TRAF6)
- Activates NF-κB, MAPKs & NFATc1
- │
- ▼
- Osteoclast Differentiation, Fusion,
- Activation & Survival ──▶ BONE RESORPTION
RANKL (Receptor Activator of Nuclear Factor-κB Ligand):
A membrane-bound or cleaved soluble cytokine expressed by osteoblasts, osteocytes, and activated T- and B-lymphocytes .
Binds to its specific cognate transmembrane receptor, RANK , located on the surface of osteoclast progenitor monocytes and mature osteoclasts.
RANK (Receptor):
Binding of RANKL to RANK recruits intracellular adapter proteins, primarily TRAF6 (TNF Receptor-Associated Factor 6) .
TRAF6 triggers downstream phosphorylation of the NF-κB pathway and Mitogen-Activated Protein Kinases (MAPKs: p38, JNK, ERK) .
This induces the expression and auto-amplification of NFATc1 (Nuclear Factor of Activated T-cells c1) , the master transcription factor required for osteoclast precursor fusion into multinucleated cells, activation of the ruffled border, and expression of TRAP and Cathepsin K.
OPG (Osteoprotegerin):
A soluble, circulating glycoprotein secreted by osteoblasts and marrow stromal cells .
Functions as a physiological decoy receptor that binds RANKL with high affinity, physically preventing RANKL from docking to its receptor RANK.
Consequently, OPG terminates osteoclastogenesis and induces apoptosis in mature osteoclasts, acting as a natural brake on bone resorption.
Clinical and Pathological Signalling
The ratio of RANKL to OPG determines the rate of bone resorption. When the RANKL/OPG ratio increases, bone resorption accelerates; when OPG levels exceed RANKL, bone mass is preserved or increased.
In Periodontitis and Periapical Pathoses: Bacterial lipopolysaccharide (LPS) activates local immune and stromal cells, inducing massive secretion of pro-inflammatory mediators ( IL-1β, TNF-α, IL-6, and PGE₂ ). These cytokines dramatically upregulate RANKL while downregulating OPG, driving extensive alveolar bone destruction.
Denosumab: A fully human monoclonal antibody (IgG₂) used in osteoporosis and oncology that specifically binds and neutralizes human RANKL. It functions pharmacologically as a synthetic, high-potency mimic of OPG, halting osteoclastogenesis.
Sections you finish are checked off in the contents.
- Up Next
- 7.3 Endocrine Control of Calcium and Phosphate
- Continue learning